Cargando…
Pharmacoepigenetics in Heart Failure
Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenot...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875470/ https://www.ncbi.nlm.nih.gov/pubmed/20424992 http://dx.doi.org/10.1007/s11897-010-0011-y |
_version_ | 1782181580368773120 |
---|---|
author | Mateo Leach, Irene van der Harst, Pim de Boer, Rudolf A. |
author_facet | Mateo Leach, Irene van der Harst, Pim de Boer, Rudolf A. |
author_sort | Mateo Leach, Irene |
collection | PubMed |
description | Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenotypic variation, but that epigenetic changes also play an important role in the variation of predisposition to disease and to drug response. In this review, we discuss recent evidence of epigenetic changes that play an important role in the development of cardiac hypertrophy and heart failure and may dictate response to therapy. |
format | Text |
id | pubmed-2875470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-28754702010-06-10 Pharmacoepigenetics in Heart Failure Mateo Leach, Irene van der Harst, Pim de Boer, Rudolf A. Curr Heart Fail Rep Article Epigenetics studies inheritable changes of genes and gene expression that do not concern DNA nucleotide variation. Such modifications include DNA methylation, several forms of histone modification, and microRNAs. From recent studies, we know not only that genetic changes account for heritable phenotypic variation, but that epigenetic changes also play an important role in the variation of predisposition to disease and to drug response. In this review, we discuss recent evidence of epigenetic changes that play an important role in the development of cardiac hypertrophy and heart failure and may dictate response to therapy. Current Science Inc. 2010-04-21 2010 /pmc/articles/PMC2875470/ /pubmed/20424992 http://dx.doi.org/10.1007/s11897-010-0011-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Mateo Leach, Irene van der Harst, Pim de Boer, Rudolf A. Pharmacoepigenetics in Heart Failure |
title | Pharmacoepigenetics in Heart Failure |
title_full | Pharmacoepigenetics in Heart Failure |
title_fullStr | Pharmacoepigenetics in Heart Failure |
title_full_unstemmed | Pharmacoepigenetics in Heart Failure |
title_short | Pharmacoepigenetics in Heart Failure |
title_sort | pharmacoepigenetics in heart failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875470/ https://www.ncbi.nlm.nih.gov/pubmed/20424992 http://dx.doi.org/10.1007/s11897-010-0011-y |
work_keys_str_mv | AT mateoleachirene pharmacoepigeneticsinheartfailure AT vanderharstpim pharmacoepigeneticsinheartfailure AT deboerrudolfa pharmacoepigeneticsinheartfailure |